Stockreport

Regeneron's C5 Milestones And Autoimmune Bets Shape Future Valuation [Yahoo! Finance]

Regeneron Pharmaceuticals, Inc.  (REGN) 
Last regeneron pharmaceuticals, inc. earnings: 2/6 06:30 am Check Earnings Report
US:NASDAQ Investor Relations: investor.regeneron.com
PDF Regeneron Pharmaceuticals (NasdaqGS:REGN) reports multiple milestones in its C5 complement program, including completion of enrollment in its pivotal paroxysmal nocturn [Read more]